IRVINE, Calif., May 12, 2011 /PRNewswire/ -- Irvine Pharmaceutical Services is excited to announce the addition of Dr. Dorla Mirejovsky, as the Senior Director of Formulation Development. Dr. Mirejovsky brings with her over 25 years of experience in pharmaceutical development, drug delivery, and manufacturing of injectable drugs.
Dr. Mirejovsky most
Dr. Mirejovsky holds a Ph.D. in Physical Organic Chemistry from the University of Utrecht, Utrecht, The Netherlands preceded by a Diplome d'ingenieur d'ENSCP - Ecole Nationale Superieure de Chimie de Paris, Paris, France. She was a postdoctoral fellow at the Department of Chemistry, Northwestern University, Evanston, Illinois and at the Department of Chemistry, Duke University, Durham, North Carolina.
You can learn more about Irvine and the executive team at the upcoming 2011 AAPS National Biotech Conference in San Francisco, California, May 16-18, 2011. Visit us at our affiliate, Avrio Biopharma's booth 53!
Irvine Pharmaceutical Services, Inc. along with its affiliate, Avrio Biopharma, is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Irvine and Avrio together provide full cGMP specialized product development services such as, preformulation/formulation, analytical development, aseptic fill-and-finish, stability storage and complete analytical CMC testing. Learn more at www.irvinepharma.com or call 877-445-6554.
SOURCE Irvine Pharmaceutical Services, Inc.
Subscribe to our Free Newsletters!
Statins are a group of drugs which help to lower the blood cholesterol levels.
Niemann-Pick disease is a group of inherited metabolic disorders in which cholesterol and lipids ...
Raspberries are packed with important nutrients, vitamins and minerals. They help boost immunity, ...View All